We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » DEA Tightens Controls on Hydrocodone Combo Product Painkillers as Schedule II Drugs
DEA Tightens Controls on Hydrocodone Combo Product Painkillers as Schedule II Drugs
In a widely expected move, the Drug Enforcement Administration has clamped down on misuse of hydrocodone combination products (HCPs) by classifying them as Schedule II controlled substances, a designation that already applies to oxycodone and non-combo hydrocodone painkillers.